High-Dose Therapy and Autologous Stem Cell Transplantation for Chemoresistant Hodgkin Lymphoma: The Seattle Experience

BACKGROUND: High-dose therapy (HDT) with autologous stem cell transplantation (ASCT) is the standard treatment for patients with chemosensitive relapsed/refractory Hodgkin lymphoma (HL), but this therapy is commonly denied to patients with resistant disease. We explored the utility of HDT and ASCT f...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Gopal, Ajay K, Metcalfe, Tracee L, Gooley, Ted A, Pagel, John M, Petersdorf, Stephen H, Bensinger, William I, Holmberg, Leona, Maloney, David G, Press, Oliver W
Format: Artigo
Jezik:Inglês
Izdano: 2008
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2700660/
https://ncbi.nlm.nih.gov/pubmed/18623377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.23715
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items